Research News and Research

RSS

AFRESA Inhalation Powder and AFRESA Inhaler NDA under FDA review

AFRESA® (insulin human [rDNA origin]) Inhalation Powder is a well-tolerated, ultra rapid acting insulin able to more closely replicate normal glucose suppression than currently available insulins, according to data presented at the 45th Annual Meeting of the European Association for the Study of Diabetes.

30 Sep 2009

New treatment for Alzheimer's disease may be in the offing

Oleocanthal, a naturally-occurring compound found in extra-virgin olive oil, alters the structure of neurotoxic proteins believed to contribute to the debilitating effects of Alzheimer's disease. This structural change impedes the proteins' ability to damage brain nerve cells.

30 Sep 2009

Metabolomics identifies biomarkers for periodontitis and gingivitis

...

30 Sep 2009

Reuters examines how HIV vaccine trial results will guide future studies

Reuters reports on how the results of an experimental AIDS vaccine, which showed modest potential for preventing infection, are leading researchers back "to the drawing board" as they try to better understand how the AIDS vaccine works.

30 Sep 2009

The still elusive malaria vaccine

A deadly disease, malaria afflicts 350-500 million people worldwide each year and kills more than a million people. Transmitted by Anopheles mosquitoes, the disease occurs in more than 100 countries and territories, with at least 40 percent of the world's population at risk.

30 Sep 2009

EnWave receives R&D funding to develop REV dehydration technologies

EnWave Corporation (TSX VENTURE:ENW)(FRANKFURT:E4U) ("EnWave" or "the Company") today announced that it has received research and development funding from three separate Canadian federal and provincial government agencies totaling $370,000 to continue the Company's development of its Radiant Energy Vacuum ("REV") dehydration technology for food, food cultures, and biopharmaceuticals.

30 Sep 2009

Nutraceutix receives Chinese patent for probiotic and nutraceutical delivery technology

The Chinese Patent Office has issued Nutraceutix, Inc. patent No. 02823678.5 for BIO-tract. It is the fourth international patent, from many patents pending, that the technology has been awarded recently based on BIO-tract's ability to protect sensitive ingredients such as probiotic organisms from stomach acid on their way to optimal release sites in the intestinal tract.

30 Sep 2009

Promised e-health improvements also come with shortcomings, risks

Efforts to achieve greater efficiency and higher quality in health care through new health information technologies are not without new risks as well.

30 Sep 2009

Pfizer and Composite Software executives to present at Butler Group’s BI Symposium

Composite Software, the leading provider of data virtualization software, today announced that a senior executive from Pfizer (a Composite customer) and a senior Composite executive will present at the Butler Group’s Business Intelligence (BI) Symposium. “BI Foundations for Decision-Making Excellence and Risk Management” is scheduled for October 7-8, 2009, at the America Square Conference Centre in London.

30 Sep 2009

Environmental factors play a major role in early pregnancy losses

Life is all about tradeoffs and recently published research by Virginia J. Vitzthum, a senior scientist at Indiana University's Kinsey Institute for Research in Sex, Gender, and Reproduction, and professor in the IU College of Arts and Sciences' Department of Anthropology, has shown that during periods of intense labor and low food intake, rates of early pregnancy loss can more than double.

30 Sep 2009

Poll: Support for Democratic health plan hits new low

"Just 41% of voters nationwide now favor the health care reform proposed by President Obama and congressional Democrats. That's down two points from a week ago and the lowest level of support yet measured," Rasmussen reports on its latest poll.

30 Sep 2009

ASU receives $32 million as research grants

Arizona State University researchers to date have received more than $32 million in stimulus package research grants. For ASU, which has played a very active role in attracting this additional funding, much of these research funds have gone for projects that meet challenges currently confronting society.

30 Sep 2009

Memorial Sloan-Kettering Cancer Center awards $50,000 to three young investigators

Three young investigators who have taken significant steps toward advancing the understanding of cancer will be the recipients of this year's Paul Marks Prize for Cancer Research, a prize awarded biennially since 2001 to scientists under the age of forty-six by Memorial Sloan-Kettering Cancer Center.

30 Sep 2009

ABL partners with Evivar Medical to develop and commercialize clinical management tools

Advanced Biological Laboratories S.A (ABL) and Evivar Medical Pty Ltd (Evivar) today announced the completion of agreements to cross-licence their respective intellectual property portfolios, and to form strategic alliances based on the use of their proprietary disease management platforms in HIV and Hepatitis B.

30 Sep 2009

Medical students increasingly spurning primary care

The Baltimore Sun reports: "Ryan Circh's heart is drawn to family medicine, but his head - fixated on his daunting student loans and the uncertainties of health care reform - is leading him toward emergency or sports medicine. The 24-year-old studying medicine at the University of Maryland is probably another potential primary care physician lost. In the school's most recent graduating medical school class, more than a third pursued internal and family medicine."

30 Sep 2009

Democrats ready to battle amongst themselves over public plan

Democrats are set to spar — among themselves — on inclusion of a government-run public option for health insurance coverage during Finance Committee action today.

30 Sep 2009

TGen's annual economic impact can grow to $321 million by 2025

The Translational Genomics Research Institute (TGen) provides Arizona with an annual total economic impact of $77.4 million, according to the results of an independent analysis released today.

30 Sep 2009

Researchers find new ways to treat Myelodysplastic Syndrome

Van Andel Research Institute (VARI) researchers are one step closer to finding new ways to treat Myelodysplastic Syndrome (MDS), a bone marrow disease that strikes up to 15,000 people each year in the United States, and that sometimes results in acute myeloid leukemia.

30 Sep 2009

Women making poor shoe choices suffer with hindfoot pain

A recently published study determined that women who make poor shoe choices early in life suffer with foot pain in later years. Research shows that men do not experience the same foot pain as women, due to type of shoes they wear. Details of this study appear in the October issue of Arthritis Care & Research, a journal published by Wiley-Blackwell on behalf of the American College of Rheumatology.

30 Sep 2009

Fact checking anecdotes: Obama wrong on particulars in cancer and acne insurance denial case

When President Obama recently recounted the story of a woman he said was denied coverage for failure to own up to a skin condition when she enrolled in a plan, he was incorrect, The Associated Press reports.

30 Sep 2009